Biomedical subjects

D Kaigler

Publications and source records attributed to D Kaigler.

6 recordsLinked to original sources

PubMed2006

Transplanted endothelial cells enhance orthotopic bone regeneration.

The aim of this study was to determine if endothelial cells could enhance bone marrow stromal-cell-mediated bone regeneration in an osseous defect. Using poly-lactide-co-glycolide scaffolds as cell carriers, we transplanted bone marrow stromal cells alone or with endothelial cells into 8.5-mm calvarial defects created in nude rats. Histological analyses of blood vessel and bone formation were performed, and microcomputed tomography (muCT) was used to assess mineralized bone matrix. Though the magnitude of the angiogenic response between groups was the same, muCT analysis revealed earlier mineralization of bone in the co-transplantation condition. Ultimately, there was a significant increase (40%) in bone formation in the co-transplantation group (33 +/- 2%), compared with the transplantation of bone marrow stromal cells alone (23 +/- 3%). Analysis of these data demonstrates that, in an orthotopic site, transplanted endothelial cells can influence the bone-regenerative capacity of bone marrow stromal cells.

Absorbable Implants↗

PubMed2005

Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4).

Gene therapy approaches to bone tissue engineering have been widely explored. While localized delivery of plasmid DNA encoding for osteogenic factors is attractive for promoting bone regeneration, the low transfection efficiency inherent with plasmid delivery may limit this approach. We hypothesized that this limitation could be overcome by condensing plasmid DNA with nonviral vectors such as poly(ethylenimine) (PEI), and delivering the plasmid DNA in a sustained and localized manner from poly(lactic-co-glycolic acid) (PLGA) scaffolds. To address this possibility, scaffolds delivering plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4) were implanted into a cranial critical-sized defect for time periods up to 15 weeks. The control conditions included no scaffold (defect left empty), blank scaffolds (no delivered DNA), and scaffolds encapsulating plasmid DNA (non-condensed). Histological and microcomputed tomography analysis of the defect sites over time demonstrated that bone regeneration was significant at the defect edges and within the defect site when scaffolds encapsulating condensed DNA were placed in the defect. In contrast, bone formation was mainly confined to the defect edges within scaffolds encapsulating plasmid DNA, and when blank scaffolds were used to fill the defect. Histomorphometric analysis revealed a significant increase in total bone formation (at least 4.5-fold) within scaffolds incorporating condensed DNA, relative to blank scaffolds and scaffolds incorporating uncondensed DNA at each time point. In addition, there was a significant increase both in osteoid and mineralized tissue density within scaffolds incorporating condensed DNA, when compared with blank scaffolds and scaffolds incorporating uncondensed DNA, suggesting that delivery of condensed DNA led to more complete mineralized tissue regeneration within the defect area. This study demonstrated that the scaffold delivery system encapsulating PEI-condensed DNA encoding for BMP-4 was capable of enhancing bone formation and may find applications in other tissue types.

Animals↗

PubMed2004

Bone regeneration via a mineral substrate and induced angiogenesis.

Angiogenesis and biomineral substrates play major roles in bone development and regeneration. We hypothesized that macroporous scaffolds of biomineralized 85:15 poly(lactide-co-glycolide), which locally release vascular endothelial growth factor-165 (VEGF), would direct simultaneous regeneration of bone and vascular tissue. The presence of a bone-like biomineral substrate significantly increased regeneration of osteoid matrix (32 +/- 7% of total tissue area; mean +/- SD; p < 0.05) and mineralized tissue (14 +/- 2%; P < 0.05) within a rat cranium critical defect compared with a non-mineralized polymer scaffold (19 +/- 8% osteoid and 10 +/- 2% mineralized tissue). Further, the addition of VEGF to a mineralized substrate significantly increased the generation of mineralized tissue (19 +/- 4%; P < 0.05) compared with mineralized substrate alone. This appeared to be due to a significant increase in vascularization throughout VEGF-releasing scaffolds (52 +/- 9 vessels/mm(2); P < 0.05) compared with mineralized scaffolds without VEGF (34 +/- 4 vessels/mm(2)). Surprisingly, there was no significant difference in total osteoid between the two samples, suggesting that increased vascularization enhances mineralized tissue generation, but not necessarily osteoid formation. These results indicate that induced angiogenesis can enhance tissue regeneration, supporting the concept of therapeutic angiogenesis in tissue-engineering strategies.

Analysis of Variance↗

PubMed2001

Tissue engineering's impact on dentistry.

Tissue engineering is a novel and exciting field that aims to re-create functional, healthy tissues and organs in order to replace diseased, dying, or dead tissues. The field has developed due to the inadequate supply of organs and tissues for patients requiring organ and tissue replacement. The following review first describes three major tissue engineering strategies. Although similar in their objectives, these strategies each maintain a unique component. Next, several examples of preclinical and clinical progress engineering oral-maxillofacial tissues are presented. Each of these examples highlights specific tissue engineering applications to different tissues of the oral-maxillofacial apparatus. Finally, practical implications are addressed as well as challenges that must be met in order for tissue engineering to reach its full potential.

Biocompatible Materials↗

PubMed1992

Early detection of osseointegration using scanning electron microscopy and the interfacial biopsy chamber: a pilot study.

This pilot project attempted to demonstrate microscopic evidence of osseointegration in a controlled environment as originally presented by Brånemark. The Interfacial Biopsy Chamber was developed to collect titanium/tissue serial biopsies of the implant-tissue interface at various stages of wound healing. It was surgically placed in two Flemish giant rabbits and titanium/tissue biopsies were collected at 35 and 70 days. The biopsies were examined using scanning electron microscopy (x2000, x3200, and x7500) and light microscopy (x230). Osseous tissue was found in intimate contact with the titanium implant surface with no evidence of an intervening fibrous layer. Cells with the morphological characteristics of osteoblasts were observed covering the titanium surface. Processes extending from the main body of these cells were in intimate contact with the titanium surface, following the machining striations. The photomicrographs were similar to those presented earlier by Brånemark. The project also suggested the use of the Interfacial Biopsy Chamber as a research instrument for the collection of implant/tissue interface serial biopsy samples.

Animals↗

PubMed1989

The bone biopsy chamber: an improved method of collecting osseous tissue.

The bone biopsy chamber (BBC) has been developed for implantation in bone to permit the serial biopsy of osseous tissues to study osseointegration. This device improves the currently available methodology for studying the implant/osseous interfacial zone by providing a means of collecting osseous samples for microscopic evaluation in the least invasive manner, and without euthanization or en bloc resection. The advantages of the BBC were verified through its implantation in the tibia of five young adult Flemish Giant rabbits and the serial collection of osseous samples. Following the recommended surgical procedures to implant the BBC and obtain osseointegration, osseous samples were collected from the five rabbits at 30-, 60-, and 90-day test periods for histologic evaluations. Bone specimens were embedded in preparation for staining using modified goldner trichrome, toluidine blue, and gallocyanin. Each of the sections demonstrated clear evidence of biocompatibility, the different cellular components and stages of osteogenesis, and that osseous tissue biopsies were possible using this device.

Animals↗